Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

Medacta Group SA Board/Management Information 2020

Mar 18, 2020

926_rns_2020-03-18_2bd45e6f-ce7e-4404-acd7-fe06ef415910.html

Board/Management Information

Open in viewer

Opens in your device viewer

News Details

Ad-hoc | 18 March 2020 07:00

Changes in the Board of Directors of Medacta Group SA

Medacta Group SA / Key word(s): Corporate Action

18-March-2020 / 07:00 CET/CEST

Release of an ad hoc announcement pursuant to Art. 53 KR

The issuer is solely responsible for the content of this announcement.


Press Release

CHANGES IN THE BOARD OF DIRECTORS OF MEDACTA GROUP SA

CASTEL SAN PIETRO , 18 March 2020 – Medacta announces that due to his various other commitments, Mr. Marco Gadola will not stand for re-election to the board of directors of Medacta Group SA at the forthcoming annual general meeting scheduled for 19 May 2020. Medacta wishes to thank Mr. Gadola for his contribution and wishes him all the best for his future endeavours. At present Medacta has no plan to nominate a substitute for Mr. Gadola but will consider this in the preparations of the forthcoming annual general meeting of Medacta.

Contact

Medacta Group SA

Corrado Farsetta, CFO

Phone: +41 91 696 60 60

[email protected]

About Medacta:

Medacta is an international company specializing in the design and production of innovative orthopaedic products and the development of accompanying surgical techniques for joint replacement, spine surgery, and sports medicine. Established in 1999 in Switzerland, Medacta’s products and surgical techniques are characterized by innovation. Medacta is a pioneer in developing new offerings on the basis of minimally invasive surgical techniques, in particular its Anterior Minimally Invasive Surgery (“AMIS”) technique for hip replacements. Medacta has leveraged its orthopaedic expertise and comprehensive understanding of the human body to develop the sophisticated “ MySolutions ” technology, which offers surgeons highly personalized pre-operative planning and implant placement methodologies by creating advanced personalized kinematic models and 3D planning tools for use in hip, knee, shoulder and spine procedures.


End of ad hoc announcement


Language: English
Company: Medacta Group SA
Strada Regina
6874 Castel San Pietro
Switzerland
Phone: +41 91 696 6060
E-mail: [email protected], [email protected]
Internet: www.medacta.com
ISIN: CH0468525222
Listed: SIX Swiss Exchange
EQS News ID: 999913
End of Announcement EQS Group News Service

show this